| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |